[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

U.S. Patient Monitoring Devices Market - Forecast to 2026

April 2020 | 322 pages | ID: U7D1D3402494EN
IQ4I Research & Consultancy Pvt. Ltd.

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Patient monitoring devices provide assistance in continuous measurement of a patient’s health parameter such as heart rate, respiratory rate, blood pressure, blood oxygen saturation and many other parameters which has become a common feature of all healthcare settings. The U.S. Patient monitoring market is is expected to reach $13,110.7 million by 2026 growing at low single digit CAGR. The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth. However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.

The U.S. patient monitoring market segmented based on device type, portability and end-users. The market by devices type is segmented into neuromonitoring, hemodynamic monitoring, blood glucose monitoring, cardiac monitoring, fetal & neonatal care monitoring, respiratory care monitoring, multi-parameter monitoring, temperature monitoring and remote patient monitoring. According to IQ4I research, Blood glucose monitoring accounted for the largest revenue of in 2019 and expected to grow at a low single digit CAGR from 2019 to 2026. Remote patient monitoring is expected to grow at a high single digit CAGR 2019 to 2026 due to increasing demand by patients for home healthcare and increasing connectivity of rural areas.

The U.S. neuromonitoring devices market is further classified into electroencephalography (EEG) devices, cerebral oximeters, intracranial pressure (ICP) monitors, magnetoencephalography (MEG) and electromyography machines (EMG). Among them, the EEG devices segment holds the largest revenue in 2019 is expected to grow at high single digit CAGR from 2019 to 2026. Increasing incidence of neurological diseases, increasing demand by neurologists and patients for advanced monitoring techniques are the factors driving the market growth.

The U.S. hemodynamic monitoring devices market is classified into Blood pressure monitors and cardiac output monitors. Among them, the cardiac output monitoring devices held the largest revenue in 2019 and is expected to grow at a low single digit CAGR. Increasing the incidence of cardiovascular diseases due to lifestyle changes and rising demand for patient monitoring devices in non-hospital settings are the factors driving the market.

The U.S. blood glucose monitoring devices market is classified into SBGM and CGM. Among the segments, CGM generated the largest revenue in 2019 and is expected to grow at a strong mid single digit CAGR from 2019 to 2026.

The U.S. cardiac monitoring device market is further segmented into event monitors, 12-Lead ECG and Holter monitors, among these, Holter monitor accounted the largest revenue in 2019 and expected to grow at high double CAGR from 2019 to 2026.

The U.S. fetal and Neonatal device market is classified into fetal monitors, fetal Doppler, infant incubators and neonatal monitoring devices. Among these, infant incubators accounted for the largest revenue in 2019 and expected to grow at a mid single digit CAGR from 2019 to 2026.

The U.S. respiratory care monitoring devices market is classified into capnography, spirometer, anesthesia monitoring, Polysomnography (PSG), Pulse oximetry and others. Among this, Pulse oximeter accounted for the largest revenue in 2019. Rising incidence of respiratory and cardiac disorders, rising adoption in homecare settings, growing demand for wireless pulse oximeters and launch of convenient fingertip and wrist pulse oximeters are the factors driving the market. Capnography devices are the fastest growing segment with a high single digit CAGR from 2019 to 2026.

The U.S. Multi-parameter monitoring devices market is classified into High acuity, Mid-acuity, and Low-acuity devices. Among the multi-parameter monitoring devices product segments, high acuity devices commanded the largest revenue in 2019. The integration of advanced technology within the high-acuity multi-parameter patient monitors has fostered its adoption in intensive care units and hospitals that help in the treatment of several chronic diseases are the factors driving the market. And low acuity segment is expected to be the fastest-growing segment from 2019 to 2026. Low-acuity monitors usually have high preference in ambulatory surgical centers and hospitals covered because they are easy to use, accurate, mobile and low price as compared to the high-acuity multi-parameter patient monitors are making them device of choice.

The U.S. temperature monitoring devices market is classified into digital thermometers, Infrared thermometers, and others (thermometer strips). Among them, the digital thermometer commanded the largest revenue in 2019 and is expected to grow at low single digit CAGR from 2019 to 2026. With the increasing prevalence of chronic and infectious diseases driving the market, the infrared thermometer market is expected to be the fastest-growing segment from 2019 to 2026. Due to These devices do not involve touching or contacting anybody's surface so the risk of cross-infection is negligible.

The U.S. remote patient monitoring (RPM) devices are classified into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices and multi-parameter monitoring devices and others. Among these, the Cardiac monitoring segment accounted for the largest revenue in 2019 and is expected to grow at double digit CAGR from 2019 to 2026. An increase in the prevalence of cardiac disorder, an increase in the prevalence of the geriatric population who are more prone to chronic disorders are the factors that increase the usage of RPM devices..

The U.S. patient monitoring devices market is further segmented based on the portability into stationary, portable, wearable and implantable. Among these, portable accounted for the largest revenue in 2019 and is expected to grow at mid single digit CAGR from 2019 to 2026.

The U.S. monitoring market based on end-user is segmented into hospital, ambulatory, homecare and others. Among these, the hospital accounted for the largest revenue in 2019 and is expected to grow at low single digit CAGR from 2019 to 2026. The homecare market is expected to be the fastest-growing segment with mid single digit CAGR from 2019 to 2026 due to the improvement and acceptance of home care devices has increased.

Major players in the U.S. patient monitoring device market are Medtronic PLC (Ireland), Dexcom Inc. (U.S.), Masimo Corporation (Switzerland), Abbott Laboratories (U.S.), BioTelemetry Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Natus medical incorporated (U.S.), iRhythm Technologies, Inc (U.S.) and Dragerwerk AG & Co. KGaA (Germany).
1 EXECUTIVE SUMMARY

2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
  2.5.1 MARKET SIZE ESTIMATION
  2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
  2.5.3 SECONDARY SOURCES
  2.5.4 PRIMARY SOURCES
  2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
  2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
  2.5.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
  3.3.1 DRIVERS AND OPPORTUNITIES
    3.3.1.1 Increase in the rate of surgeries and diseased population require continuous monitoring.
    3.3.1.2 Increasing demand for portable and remote patient monitoring devices.
    3.3.1.3 Increasing funding and investment in patient monitoring
    3.3.1.4 Favorable reimbursement policies
    3.3.1.5 Technological advancements
  3.3.2 RESTRAINTS AND THREATS
    3.3.2.1 The high cost of patient monitoring devices
    3.3.2.2 Patient safety and inaccuracy concern associated with patient monitoring devices
    3.3.2.3 Increased product recalls
    3.3.2.4 Lack of cyber-security in wireless patient monitoring devices
    3.3.2.5 Stringent regulatory requirements for new products
3.4 REGULATORY AFFAIRS
  3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
    3.4.1.1 ISO 9001: 2015 quality management system
    3.4.1.2 ISO 13485 Medical Devices
  3.4.2 THE U.S.
3.5 TECHNOLOGICAL ADVANCEMENTS
  3.5.1 BIOSTICKER
  3.5.2 ARTIFICIAL INTELLIGENCE IN PATIENT MONITORING DEVICES
  3.5.3 WEARABLE PATIENT MONITORING DEVICES
  3.5.4 IOT IN PATIENT MONITORING SYSTEM
  3.5.5 HOME DIALYSIS REMOTE PATIENT MONITORING SYSTEM
3.6 PORTER’S FIVE FORCE ANALYSIS
  3.6.1 THREAT OF NEW ENTRANTS
  3.6.2 THREAT OF SUBSTITUTES
  3.6.3 RIVALRY AMONG EXISTING COMPETITORS
  3.6.4 BARGAINING POWER OF SUPPLIERS
  3.6.5 BARGAINING POWER OF BUYERS
3.7 SUPPLY CHAIN ANALYSIS
3.8 CLINICAL TRIALS
3.9 MARKET SHARE ANALYSIS
  3.9.1 U.S.CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS
  3.9.2 U.S.HEMODYNAMIC MONITORS MARKET SHARE ANALYSIS
  3.9.3 U.S. REMOTE PATIENT MONITORING DEVICES MARKET SHARE ANALYSIS
  3.9.4 U.S.MULTI-PARAMETER MONITORS DEVICES MARKET SHARE ANALYSIS
  3.9.5 U.S. CONTINUOUS GLUCOSE MONITORING MARKET SHARE ANALYSIS
  3.9.6 U.S. DEPTH OF ANESTHESIA MARKET SHARE ANALYSIS
  3.9.7 U.S. PULSE OXIMETER MARKET SHARE ANALYSIS
  3.9.8 U.S. CEREBRAL OXIMETER MARKET SHARE ANALYSIS
  3.9.9 U.S. ICP MARKET SHARE ANALYSIS
  3.9.10 U.S. BP MONITOR MARKET SHARE ANALYSIS
  3.9.11 U.S. EEG MARKET SHARE ANALYSIS
  3.9.12 U.S. HOLTER MONITOR MARKET SHARE ANALYSIS
  3.9.13 U.S. MOBILE CARDIAC TELEMETRY (MCT) MARKET SHARE ANALYSIS
  3.9.14 U.S.CAPNOGRAPHY MARKET SHARE ANALYSIS
3.10 PATIENT MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
  3.10.1 U.S. EEG, ICP, ELECTROMYOGRAPHY, AND CEREBRAL OXIMETERS NUMBER OF UNITS SOLD AND INSTALLED BASE
  3.10.2 U.S. HEMODYNAMIC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
  3.10.3 U.S. CARDIAC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE
  3.10.4 U.S. FETAL DOPPLERS, FETAL MONITORS AND INFANT INCUBATORS NUMBER OF UNITS SOLD AND INSTALLED BASE
  3.10.5 U.S.SPIROMETER, CAPNOGRAPY, ANESTHESIA MONITORING NUMBER OF UNITS SOLD AND INSTALLED BASE
  3.10.6 U.S. PULSE OXIMETER (FINGERTIP, WIRST, HANDHELD, TABLETOP AND MRI) UNITS SOLD AND INSTALLED BASE
  3.10.7 U.S. TEMPERATURE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE

4 PATIENT MONITORING DEVICES MARKET, BY DEVICES

4.1 INTRODUCTION
4.2 NEUROMONITORING DEVICES
  4.2.1 ELECTROENCEPHALOGRAPH (EEG)
  4.2.2 CEREBRAL OXIMETER
  4.2.3 INTRACRANIAL PRESSURE MONITORS (ICP)
  4.2.4 MAGNETOENCEPHALOGRAPH (MEG)
  4.2.5 ELECTROMYOGRAPH MACHINES (EMG)
4.3 HEMODYNAMIC MONITORING DEVICES
  4.3.1 BLOOD PRESSURE MONITORS
  4.3.2 CARDIAC OUTPUT MONITORING
4.4 BLOOD GLUCOSE MONITORS
  4.4.1 SELF BLOOD GLUCOSE MONITORING (SBGM)
  4.4.2 CONTINUOUS GLUCOSE MONITORING (CGM)
4.5 CARDIAC MONITORING DEVICES
  4.5.1 12-LEADS ECG MONITORS
  4.5.2 EVENT MONITORS
  4.5.3 HOLTER MONITORS
4.6 FETAL AND NEONATAL CARE MONITORING DEVICES
  4.6.1 FETAL MONITORS
  4.6.2 FETAL DOPPLERS
  4.6.3 INFANT INCUBATORS
  4.6.4 NEONATAL MONITORING DEVICES
4.7 RESPIRATORY MONITORING DEVICES
  4.7.1 CAPNOGRAPHY
  4.7.2 SPIROMETER
  4.7.3 ANESTHESIA MONITORS
  4.7.4 POLYSOMNOGRAPHY DEVICES
  4.7.5 PULSE OXIMETERS
    4.7.5.1 Fingertip Pulse Oximeters
    4.7.5.2 Handheld Pulse Oximeters
    4.7.5.3 Tabletop Pulse Oximeters
    4.7.5.4 Other Pulse Oximeters
  4.7.6 OTHER RESPIRATORY DEVICES
4.8 MULTI-PARAMETER MONITORING DEVICES
  4.8.1 HIGH-ACUITY
  4.8.2 MID-ACUITY
  4.8.3 LOW-ACUITY
4.9 TEMPERATURE MONITORING DEVICES
  4.9.1 DIGITAL THERMOMETERS
  4.9.2 INFRARED THERMOMETERS (IR THERMOMETERS)
  4.9.3 OTHERS (THERMOMETER STRIPS)
4.10 REMOTE PATIENT MONITORING DEVICES (RPM)
  4.10.1 REMOTE NEUROMONITORING DEVICES
  4.10.2 REMOTE HEMODYNAMIC MONITORING DEVICES
  4.10.3 REMOTE CARDIAC MONITORING DEVICES
    4.10.3.1 Implantable Loop Recorder
    4.10.3.2 Mobile Cardiac Telemetry (MCT/MCOT)
  4.10.4 REMOTE MULTI-PARAMETER MONITORING DEVICES
  4.10.5 OTHER REMOTE MONITORING DEVICES

5 PATIENT MONITORING DEVICES MARKET, BY PORTABILITY

5.1 INTRODUCTION
5.2 STATIONARY PATIENT MONITORING DEVICES
5.3 PORTABLE PATIENT MONITORING DEVICES
5.4 WEARABLE PATIENT MONITORING DEVICES
5.5 IMPLANTABLE PATIENT MONITORING DEVICES

6 PATIENT MONITORING U.S. MARKET, BY END-USERS

6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTERS
6.4 HOME HEALTHCARE
6.5 OTHERS (SLEEP CENTERS, CLINICS/PHYSICIAN OFFICES, HOSPICES)

7 COMPETITIVE LANDSCAPE

7.1 INTRODUCTION
7.2 APPROVALS
7.3 NEW PRODUCT LAUNCH
7.4 AGREEMENTS, PARTNERSHIP AND COLLABORATION
7.5 ACQUISITION

8 MAJOR PLAYER PROFILES

8.1 ABBOTT LABORATORIES
  8.1.1 OVERVIEW
  8.1.2 FINANCIALS
  8.1.3 PRODUCT PORTFOLIO
  8.1.4 KEY DEVELOPMENTS
  8.1.5 BUSINESS STRATEGY
  8.1.6 SWOT ANALYSIS
8.2 BIO TELEMETRY INC
  8.2.1 OVERVIEW
  8.2.2 FINANCIALS
  8.2.3 PRODUCT PORTFOLIO
  8.2.4 KEY DEVELOPMENTS
  8.2.5 BUSINESS STRATEGY
  8.2.6 SWOT ANALYSIS
8.3 DEXCOM, INC
  8.3.1 OVERVIEW
  8.3.2 FINANCIALS
  8.3.3 PRODUCT PORTFOLIO
  8.3.4 KEY DEVELOPMENTS
  8.3.5 BUSINESS STRATEGY
  8.3.6 SWOT ANALYSIS
8.4 EDWARDS LIFESCIENCES CORPORATION.
  8.4.1 OVERVIEW
  8.4.2 FINANCIALS
  8.4.3 PRODUCT PORTFOLIO
  8.4.4 KEY DEVELOPMENTS
  8.4.5 BUSINESS STRATEGY
  8.4.6 SWOT ANALYSIS
8.5 GE HEALTHCARE
  8.5.1 OVERVIEW
  8.5.2 FINANCIALS
  8.5.3 PRODUCT PORTFOLIO
  8.5.4 KEY DEVELOPMENTS
  8.5.5 BUSINESS STRATEGY
  8.5.6 SWOT ANALYSIS
8.6 HILL-ROM HOLDINGS, INC.
  8.6.1 OVERVIEW
  8.6.2 FINANCIALS
  8.6.3 PRODUCT PORTFOLIO
  8.6.4 KEY DEVELOPMENTS
  8.6.5 BUSINESS STRATEGY
  8.6.6 SWOT ANALYSIS
8.7 IRHYTHM TECHNOLOGIES, INC.
  8.7.1 OVERVIEW
  8.7.2 FINANCIALS
  8.7.3 PRODUCT PORTFOLIO
  8.7.4 KEY DEVELOPMENTS
  8.7.5 BUSINESS STRATEGY
  8.7.6 SWOT ANALYSIS
8.8 KONINKLIJKE PHILIPS N.V.
  8.8.1 OVERVIEW
  8.8.2 FINANCIALS
  8.8.3 PRODUCT PORTFOLIO
  8.8.4 KEY DEVELOPMENTS
  8.8.5 BUSINESS STRATEGY
  8.8.6 SWOT ANALYSIS
8.9 MASIMO CORPORATION
  8.9.1 OVERVIEW
  8.9.2 FINANCIALS
  8.9.3 PRODUCT PORTFOLIO
  8.9.4 KEY DEVELOPMENTS
  8.9.5 BUSINESS STRATEGY
  8.9.6 SWOT ANALYSIS
8.10 MEDTRONIC, PLC
  8.10.1 OVERVIEW
  8.10.2 FINANCIALS
  8.10.3 PRODUCT PORTFOLIO
  8.10.4 KEY DEVELOPMENTS
  8.10.5 BUSINESS STRATEGY
  8.10.6 SWOT ANALYSIS
8.11 NATUS MEDICAL INCORPORATED.
  8.11.1 OVERVIEW
  8.11.2 FINANCIALS
  8.11.3 PRODUCT PORTFOLIO
  8.11.4 KEY DEVELOPMENTS
  8.11.5 BUSINESS STRATEGY
  8.11.6 SWOT ANALYSIS
8.12 OMRON CORPORATION
  8.12.1 OVERVIEW
  8.12.2 FINANCIALS
  8.12.3 PRODUCT PORTFOLIO
  8.12.4 KEY DEVELOPMENTS
  8.12.5 BUSINESS STRATEGY
  8.12.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES TYPE, (2018-2026) ($MN)
TABLE 2 U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICES TYPE, (2018-2026) ($MN)
TABLE 3 U.S. NEUROMONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 4 U.S. HEMODYNAMIC MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 5 U.S. BLOOD GLUCOSE MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 6 U.S. CARDIAC MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 7 U.S. FETAL AND NEONATAL CARE MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 8 U.S. RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 9 U.S. PULSE OXIMETER MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 10 U.S. MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 11 U.S. TEMPERATURE MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 12 U.S. REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICE, (2018-2026) ($MN)
TABLE 13 U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY PORTABILITY, (2018-2026) ($MN)
TABLE 14 U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 15 APPROVALS (2018-2019)
TABLE 16 NEW PRODUCT LAUNCH (2018-2019)
TABLE 17 AGREEMENTS, PARTNERSHIP AND COLLABORATION (2018-2019)
TABLE 18 ACQUISITION (2018-2019)
TABLE 19 ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 20 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 21 ABBOTT LABORATORIES, INC: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 22 ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 23 BIO TELEMETRY INC COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) ($MN)
TABLE 24 BIO TELEMETRY INC COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 25 DEXCOM, INC: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 26 DEXCOM INC: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 27 DEXCOM INC: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
TABLE 28 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 29 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 30 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019)($MN)
TABLE 31 GE COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) (Q3) ($MN)
TABLE 32 GE COMPANY: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 33 GE COMPANY: TOTAL REVENUE, BY HEALTHCARE SEGMENT (2017 –2019) (Q3) ($MN)
TABLE 34 GE COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) (Q3) ($MN)
TABLE 35 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) ($MN)
TABLE 36 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 37 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) ($MN)
TABLE 38 IRHYTHM TECHNOLOGIES, INC: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 39 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 40 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 41 KONINKLIJKE PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 42 MASIMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 43 MASIMO CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) ($MN)
TABLE 44 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
TABLE 45 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q3) ($MN)
TABLE 46 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
TABLE 47 NATUS MEDICAL INCORPORATED: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 48 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 49 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY NEURO SEGMENT (2017-2019)($MN)
TABLE 50 NATUS MEDICAL CORPORATION: TOTAL REVENUE, BY REGION (2017-2019)($MN)
TABLE 51 OMRON CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017 – 2019) (Q3) ($MN)
TABLE 52 OMRON CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q3) ($MN)
TABLE 53 OMRON CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017 –2019) (Q3) ($MN)

LIST OF FIGURES

FIGURE 1 U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICE TYPE (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: U.S. PATIENT MONITORING DEVICES MARKET
FIGURE 3 U.S. PATIENT MONITORING MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 U.S. PATIENT MONITORING DEVICES MARKET: FORECASTING MODEL
FIGURE 5 U.S. PATIENT MONITORING DEVICES MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 U.S. PATIENT MONITORING DEVICES MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 U.S. PATIENT MONITORING DEVICES MARKET: PORTER’S ANALYSIS
FIGURE 9 U.S. PATIENT MONITORING DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 U.S. CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 11 U.S. CARDIAC OUTPUT MONITORING MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 12 U.S. REMOTE PATIENT MONITORING DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 13 U.S. MULTI-PARAMETER MONITORS DEVICES MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 14 U.S. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET SHARE, BY KEY PLAYERS, 2019 (%)
FIGURE 15 U.S. DEPTH OF ANESTHESIA MARKET SHARE, BY KEY PLAYERS, 2019 (%)
FIGURE 16 U.S. PULSE OXIMETER MARKET SHARE, BY KEY PLAYERS, 2019 (%)
FIGURE 17 U.S. CEREBRAL OXIMETER MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 18 U.S. ICP MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 19 U.S. BP MONITOR MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 20 U.S. EEG MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 21 U.S. HOLTER MONITOR MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 22 U.S. MOBILE CARDIAC TELEMETRY (MCT) MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 23 U.S. CAPNOGRAPHY MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
FIGURE 24 U.S. EEG, ICP, ELECTROMYOGRAPHY, AND CEREBRAL OXIMETERS NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 25 U.S. HEMODYNAMIC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 26 U.S. CARDIAC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 27 U.S. FETAL DOPPLERS, FETAL MONITORS AND INFANT INCUBATORS NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 28 U.S. SPIROMETER, CAPNOGRAPY, ANESTHESIA MONITORING NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 29 U.S. PULSE OXIMETER (FINGERTIP, WIRST, HANDHELD, TABLETOP AND MRI) NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 30 U.S. TEMPERATURE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE, (2019)
FIGURE 31 U.S. PATIENT MONITORING DEVICES MARKET REVENUE, BY DEVICE TYPE (2018-2026) ($MN)
FIGURE 32 U.S. NEUROMONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 33 U.S. HEMODYNAMIC MONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 34 U.S. BLODD GLUCOSE MONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 35 U.S. CARDIAC MONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 36 U.S. FETAL AND NEONATAL CARE MONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 37 U.S. RESPIRATORY MONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 38 U.S. MULTI-PARAMETER MONITORING MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 39 U.S. TEMPERATURE MONITORING MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 40 U.S. REMOTE PATIENT MONITORING DEVICES MARKET SHARE, BY DEVICE (2019 VS 2026) (%)
FIGURE 41 U.S. PATIENT MONITORING DEVICES MARKET SHARE, BY PROBABILITY (2019 VS 2026) (%)
FIGURE 42 U.S. PATIENT MONITORING DEVICES MARKET SHARE, BY END-USER (2019 VS 2026) (%)
FIGURE 43 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 44 SWOT: ABBOTT LABORATORIES
FIGURE 45 SWOT: BIO TELEMETRY INC.
FIGURE 46 SWOT: DEXCOM, INC.
FIGURE 47 SWOT: EDWARDS LIFESCIENCES INC.
FIGURE 48 SWOT: GE HEALTHCARE
FIGURE 49 SWOT: HILL-ROM HOLDINGS, INC.
FIGURE 50 SWOT: IRHYTHM TECHNOLOGIES, INC.
FIGURE 51 SWOT: KONINKLIJKE PHILIPS N.V.
FIGURE 52 SWOT: MASIMO CORPORATION
FIGURE 53 SWOT: MEDTRONIC, PLC
FIGURE 54 SWOT: NATUS MEDICAL CORPORATION.
FIGURE 55 SWOT: OMRON HEALTHCARE


More Publications